- Home
- PROF vs ALEC Comparison
PROF vs ALEC Comparison
Compare PROF & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROF
- ALEC
- Stock Information
- Founded
- PROF N/A
- ALEC 2013
- Country
- PROF Canada
- ALEC United States
- Employees
- PROF N/A
- ALEC N/A
- Industry
- PROF Medical/Dental Instruments
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PROF Health Care
- ALEC Health Care
- Exchange
- PROF Nasdaq
- ALEC Nasdaq
- Market Cap
- PROF 149.7M
- ALEC 124.0M
- IPO Year
- PROF N/A
- ALEC 2019
- Fundamental
- Price
- PROF $6.38
- ALEC $1.47
- Analyst Decision
- PROF Strong Buy
- ALEC Buy
- Analyst Count
- PROF 2
- ALEC 7
- Target Price
- PROF $11.50
- ALEC $4.70
- AVG Volume (30 Days)
- PROF 50.0K
- ALEC 679.0K
- Earning Date
- PROF 08-07-2025
- ALEC 08-06-2025
- Dividend Yield
- PROF N/A
- ALEC N/A
- EPS Growth
- PROF N/A
- ALEC N/A
- EPS
- PROF N/A
- ALEC N/A
- Revenue
- PROF $11,862,000.00
- ALEC $88,339,000.00
- Revenue This Year
- PROF $71.17
- ALEC N/A
- Revenue Next Year
- PROF $134.25
- ALEC $319.82
- P/E Ratio
- PROF N/A
- ALEC N/A
- Revenue Growth
- PROF 75.01
- ALEC N/A
- 52 Week Low
- PROF $3.90
- ALEC $0.87
- 52 Week High
- PROF $11.42
- ALEC $6.78
- Technical
- Relative Strength Index (RSI)
- PROF 69.47
- ALEC 53.71
- Support Level
- PROF $6.69
- ALEC $1.37
- Resistance Level
- PROF $7.02
- ALEC $1.62
- Average True Range (ATR)
- PROF 0.40
- ALEC 0.13
- MACD
- PROF 0.09
- ALEC -0.01
- Stochastic Oscillator
- PROF 69.53
- ALEC 46.34
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.